Gelatine

Gefitinib (INN) (originally coded ZD1839) is a drug used in the treatment of certain types of cancer. Acting in a similar manner to erlotinib (marketed as Tarceva), gefitinib selectively targets proteins in malignant cells. It is marketed by AstraZeneca and Teva under the trade name Iressa.

Systematic (IUPAC) name:
Gelatine CAS number:
ATC code:	L01XE02
PubChem:
DrugBank:
Formula:
Molecular mass:	g/mol
Gelatine Assay/Purity:	Typically NLT 98%

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.